Shenzhen - Delayed Quote CNY

Huadong Medicine Co., Ltd (000963.SZ)

26.52 -0.10 (-0.38%)

At close: 3:04:39 PM GMT+8

Chart Range Bar

Loading chart for 000963.SZ

Previous Close 26.62
Open 25.83
Bid 26.49 x --
Ask 26.50 x --
Day's Range 26.33 - 26.82
52 Week Range 25.63 - 43.78
Volume 17,296,066
Avg. Volume 19,119,379
Market Cap (intraday) 46.509B
Beta (5Y Monthly) -0.00
PE Ratio (TTM) 13.53
EPS (TTM) 1.96
Earnings Date --
Forward Dividend & Yield 0.93 (3.49%)
Ex-Dividend Date Sep 18, 2026
1y Target Est 36.55

Huadong Medicine Co., Ltd, together with its subsidiaries, engages in the wholesale and retail of pharmaceutical products in China and internationally. The company operates through Pharmaceutical Manufacturing, Pharmaceutical Distribution, Medical Aesthetics, and Industrial Microbiology segments. It offers Chinese medicine, immunosuppressive agents, endocrine, digestive system, antineoplastic, cardiovascular, antibiotic drugs, medical beauty field, and medical devices, as well as engages in pharmaceutical logistics and industrial microbiology activities. In addition, the company provides formulation filling, technical, transportation and warehousing services. The company has strategic collaboration with Heidelberg Pharma AG to jointly develop Antibody Drug Conjugates (ADCs). Huadong Medicine Co., Ltd was incorporated in 1993 and is headquartered in Hangzhou, China.

www.eastchinapharm.com

19,095

Full Time Employees

December 31

Fiscal Year Ends

Healthcare

Sector

Drug Manufacturers - Specialty & Generic

Industry

Trailing total returns as of 11/2/2026, which may include dividends or other distributions. Benchmark is SSE Composite Index (000001.SS) .

YTD Return

000963.SZ

30.42%

SSE Composite Index (000001.SS)

8.34%

1-Year Return

000963.SZ

33.98%

SSE Composite Index (000001.SS)

8.01%

3-Year Return

000963.SZ

31.51%

SSE Composite Index (000001.SS)

20.89%

5-Year Return

000963.SZ

19.36%

SSE Composite Index (000001.SS)

3.78%

Earnings Per Share (GAAP)

Revenue vs. Earnings

yearly Annual

quarterly Quarterly

yearly Annual

quarterly Quarterly

Q3 FY26

Revenue 10.95B

Earnings 911.12M

Profit Margin 8.32%

FY25

FY26

10B

0.0%

2.0%

4.0%

6.0%

8.0%

Analyst Price Targets

27.10

36.55 Average

26.52 Current

42.00 High

Analyst Recommendations

Strong Buy
Buy
Hold
Underperform
Sell

Valuation Measures

  
  
 Annual 

Market Cap
Enterprise Value
Trailing P/E
Forward P/E
PEG Ratio (current)
Price/Sales (ttm)
Price/Book (mrq)
Enterprise Value/Revenue
Enterprise Value/EBITDA

Financial Highlights

Profitability and Income Statement

Profit Margin

7.82%
Return on Assets (ttm)

6.23%
Return on Equity (ttm)

13.52%
Revenue (ttm)

43.97B
Net Income Avi to Common (ttm)

3.44B
Diluted EPS (ttm)

1.96

Balance Sheet and Cash Flow

Total Cash (mrq)

4.11B
Total Debt/Equity (mrq)

7.96%
Levered Free Cash Flow (ttm)

1.96B

000538.SZ Yunnan Baiyao Group Co.,Ltd

54.14 +0.80%

002007.SZ Hualan Biological Engineering Inc.

12.11 +0.75%

000999.SZ China Resources Sanjiu Medical & Pharmaceutical Co., Ltd.

25.56 +1.11%

000895.SZ Henan Shuanghui Investment & Development Co.,Ltd.

24.40 -0.08%

000423.SZ Dong-E-E-Jiao Co., Ltd.

49.06 +2.36%

U.S. markets close in 1h 47m

Huadong Medicine Co., Ltd (000963.SZ)

-1.08%

-4.23%

-20.48%

-32.78%

-36.22%

-27.12%

1,572.64%

Huadong Medicine Co., Ltd Overview Drug Manufacturers - Specialty & Generic / Healthcare

Full Time Employees

Fiscal Year Ends

Sector

Industry

Recent News

Performance Overview

YTD Return

1-Year Return

3-Year Return

5-Year Return

Earnings Trends

Earnings Per Share (GAAP)

Revenue vs. Earnings

Analyst Insights

Analyst Price Targets

Analyst Recommendations

Statistics

Valuation Measures

Financial Highlights

Profitability and Income Statement

Balance Sheet and Cash Flow

Company Insights

Research Reports

People Also Watch